Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Toshiya Moriwaki is active.

Publication


Featured researches published by Toshiya Moriwaki.


Bioorganic & Medicinal Chemistry Letters | 2011

Naphthol derivatives as TRPV1 inhibitors for the treatment of urinary incontinence.

Klaus Urbahns; Takeshi Yura; Muneto Mogi; Masaomi Tajimi; Hiroshi Fujishima; Tsutomu Masuda; Nagahiro Yoshida; Toshiya Moriwaki; Timothy B. Lowinger; Heinrich Meier; Fiona Chan; David Madge; Jang Bahadur Gupta

We have identified naphthol derivatives as inhibitors of the vanilloid receptor TRPV1 by high throughput screening. The initial lead showed high clearance in rats and has been optimized by enhancing the acidity of the phenol group. Compound 6b has reduced clearance, improved potency and is active in rat cystometry models of urinary incontinence after intravenous administration.


Bioorganic & Medicinal Chemistry Letters | 2012

Tetrahydro-naphthols as orally available TRPV1 inhibitors.

Klaus Urbahns; Takeshi Yura; Jang Bahadur Gupta; Masaomi Tajimi; Hiroshi Fujishima; Tsutomu Masuda; Noriyuki Yamamoto; Yuka Ikegami; Makiko Marumo; Kayo Yasoshima; Nagahiro Yoshida; Toshiya Moriwaki; David Madge; Fiona Chan; Muneto Mogi

Starting from a naphthol-based lead series with low oral bioavailability, we have identified potent TRPV1 antagonists with oral bioavailability in rats. These compounds emerged from SAR studies aimed at replacing the leads phenol structure whilst maintaining potency. Compound rac-6a is an orally available TRPV1 antagonist with single-digit nanomolar activity. The enantiomers show a low eudismic ratio at the receptor level.


Archive | 2002

Novel substituted imidazotriazinones

Ulrich Niewöhner; Maria Theresia Niewohner; Dagmar Schauss; Gerhard Konig; Martin Hendrix; Frank-Gerhard Böss; Franz-Josef van der Staay; Rudy Schreiber; Karl-Heinz Schlemmer; Toshiya Moriwaki


Archive | 2002

Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders

Yingfu Li; Akihiko Watanabe; Timothy B. Lowinger; Kevin Bacon; Norihiro Kawamura; Takuya Shintani; Tetsuo Kikuchi; Toshiya Moriwaki; Klaus Urbahns; Keiko Fukushima; Noriko Nunami; Takashi Yoshino; Toshiki Murata; Megumi Yamauchi; Hiroko Yoshino


Archive | 2004

2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders

Yingfu Li; Kevin Bacon; Hiromi Sugimoto; Keiko Fukushima; Kentaro Hashimoto; Makiko Marumo; Toshiya Moriwaki; Noriko Nunami; Naoki Tsuno; Klaus Urbahns; Nagahiro Yoshida


Archive | 2000

3-oxo-2,1-benzisoxazol-1(3H)-carboxamides for treatment of CNS diseases

Toshiya Moriwaki; Chantal Fürstner; Bernd Riedl; Jens-Kerim Ergüden; Frank Böss; Bernard Schmidt; Franz-Josef van der Staay; Werner Schröder; Karl-Heinz Schlemmer; Nagahiro Yoshida


Archive | 2003

Tetrahydro-naphthalene derivatives

Masaomi Tajimi; Toshio Kokubo; Masahiro Shiroo; Yasuhiro Tsukimi; Takeshi Yura; Klaus Urbahns; Noriyuki Yamamoto; Muneto Mogi; Hiroshi Fujishima; Tsutomu Masuda; Nagahiro Yoshida; Toshiya Moriwaki


Journal of Pharmaceutical Sciences | 2002

A recirculatory model for local absorption and disposition of ciprofloxacin by measuring portal and systemic blood concentration difference

Toshiya Moriwaki; Hiroyuki Yasui; Yukie Shigemoto; Nagahiro Yoshida


Archive | 2009

2-Phenoxy- and 2-Phenylsulfonamide Derivatives with CCR3 Antagonistic Activity for the Treatment of Inflammatory or Immunological Disorders

Yingfu Li; Kevin Bacon; Hiromi Sugimoto; Keiko Fukushima; Kentaro Hashimoto; Makiko Marumo; Toshiya Moriwaki; Noriko Nunami; Naoki Tsuno; Klaus Urbahns; Nagahiro Yoshida


Archive | 1999

New bis-benzimidazoles

Joachim Mittendorf; Rolf Henning; Siegfried Raddatz; Karl-Heinz Schlemmer; Makiko Hiraoka; Hiroshi Kadono; Muneto Mogi; Toshiya Moriwaki; Toshiki Murata; Sachiko Sakakibara; Mitsuyuki Shimada; Nagahiro Yoshida; Takashi Yoshino

Collaboration


Dive into the Toshiya Moriwaki's collaboration.

Researchain Logo
Decentralizing Knowledge